Narrow search
Showing 21 - 30 of 431,434
Cover Image
Research joint ventures : the role of financial constraints
Brunner, Philipp; Letina, Igor; Schmutzler, Armin - 2022
resources, increase the variety of pursued projects and thereby increase the probability of discovering the innovation. RJVs … improve innovation outcomes when market competition is weak and external financing conditions are bad. An RJV may increase the … innovation probability and nevertheless lower total R&D costs. RJVs that increase innovation tend to be profitable, but …
Persistent link: https://www.econbiz.de/10013362245
Cover Image
Research joint ventures : the role of financial constraints
Brunner, Philipp; Letina, Igor; Schmutzler, Armin - 2022
resources, increase the variety of pursued projects and thereby increase the probability of discovering the innovation. RJVs … improve innovation outcomes when market competition is weak and external financing conditions are bad. An RJV may increase the … innovation probability and nevertheless lower total R&D costs. RJVs that increase innovation tend to be profitable, but …
Persistent link: https://www.econbiz.de/10013277082
Cover Image
Endogenous Productivity of Demand-Induced R&D : Evidence from Pharmaceuticals
Myers, Kyle - 2019
We examine trends in the productivity of the pharmaceutical sector over the past three decades. Motivated by Ricardo's insight that productivity and rents are endogenous to demand when inputs are scarce, we examine the industry's aggregate R&D production function. Using exogenous demand shocks...
Persistent link: https://www.econbiz.de/10012900992
Cover Image
An Optimal Mechanism to Fund the Development of Vaccines Against Emerging Epidemics
Snyder, Christopher M.; Hoyt, Kendall; Gouglas, Dimitrios - National Bureau of Economic Research - 2022
We derive the optimal funding mechanism to incentivize development and production of vaccines against diseases with epidemic potential. In the model, suppliers' costs are private information and investments are noncontractible, precluding cost-reimbursement contracts, requiring fixed-price...
Persistent link: https://www.econbiz.de/10013462668
Cover Image
Financing Correlated Drug Development Projects
Lo, Andrew W. - 2020
Current business models have struggled to support early-stage drug development. In this paper, we study an alternative financing model, the mega-fund structure, to fund drug discovery. We extend the framework proposed in previous studies to account for correlation between phase transitions in...
Persistent link: https://www.econbiz.de/10012822897
Cover Image
Making Do in Making Drugs : Innovation Policy and Pharmaceutical Manufacturing
Price II, W. Nicholson - 2016
far behind the innovative manufacturing found in other industries. This lack of innovation in drug manufacturing stands in … stark contrast to the innovation present in drug discovery. Drug discovery is the focus of a calibrated innovation policy … dollars and in human lives. This article addresses the previously underappreciated role of manufacturing in innovation studies …
Persistent link: https://www.econbiz.de/10014038452
Cover Image
Productivity and heterogeneous knowledge : exploring the relationship in a sample of drug developers
Bottazzi, Giulio; Plotnikova, Tatiana - 2010
This paper aims to investigate the effect of knowledge characteristics on the total factor productivity of firms developing drugs in the pharmaceutical industry. We decompose knowledge into knowledge associated with the technological firm portfolio and knowledge related to R&D projects, which...
Persistent link: https://www.econbiz.de/10003989032
Cover Image
Guide for the granting of compulsory licenses and government use of pharmaceutical patents
Correa, Carlos María - 2020
Persistent link: https://www.econbiz.de/10012433977
Cover Image
Compulsory licensing as a remedy against excessive pricing of life-saving medicines
Kianzad, Behrang - 2024
The COVID-19 crisis intensified decade-long debates on the interaction between intellectual property rights (IPRs), competition law and access to affordable life-saving treatments and vaccines. Compulsory licensing of patented medicines is a tried-and-tested method to expand access, particularly...
Persistent link: https://www.econbiz.de/10014541546
Cover Image
Liberalization, Firm Size and R&D Performance : A Firm Level Study of Indian Pharmaceutical Industry
Pradhan, Jaya Prakash - 2009
In the present paper, it is attempted to empirically verify the impact of economic liberalization on the R&D behaviour of Indian pharmaceutical firms controlling for the effects of several firm specific characteristics including firm size. The results from the Tobit analysis for a sample of...
Persistent link: https://www.econbiz.de/10013153453